Study reveals the importance of physical activity for healthy aging

Il­lu­mi­na’s stock rose af­ter re­port­ing stronger quar­ter­ly rev­enue than ex­pect­ed, while com­pa­ny ex­ec­u­tives dur­ing the JP Mor­gan Health­care Con­fer­ence in­di­cat­ed can­cer-test­ing sub­sidiary Grail won’t be di­vest­ed im­mi­nent­ly. The

Mer­sana Ther­a­peu­tics will lay off about half its work­force and repri­or­i­tize af­ter a Phase III tri­al fail­ure in plat­inum-re­sis­tant ovar­i­an can­cer, send­ing shares $MRSN tank­ing

John­son & John­son’s streak of tri­al wins for its block­buster drug Trem­fya has come to an end. The block­buster drug failed in a Phase 2